Status:

RECRUITING

Comorbidity Management in Rheumatic Disease.

Lead Sponsor:

Western University, Canada

Collaborating Sponsors:

Canadian Rheumatology Association (CIORA)

Conditions:

Rheumatoid Arthritis

Comorbidities and Coexisting Conditions

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Rheumatoid arthritis is a disease where the immune system attacks the body by mistake, causing inflammation of the joints and other body parts. People with rheumatoid arthritis are at higher risk of i...

Eligibility Criteria

Inclusion

  • Patients of the Waterloo Rheumatology Community Clinic
  • Aged 18 to 80 years of age
  • Diagnosis of rheumatoid arthritis
  • Minimum of limited working proficiency in English
  • No significant cognitive impairment that can inhibit their ability to engage in the study

Exclusion

  • Age less than 18 years or greater than 80 years
  • Significant cognitive impairment that impedes ability to engage in the study
  • Unwilling to participate in the study
  • Patients currently pregnant will be excluded from the study

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 19 2026

Estimated Enrollment :

199 Patients enrolled

Trial Details

Trial ID

NCT06579222

Start Date

May 1 2025

End Date

December 19 2026

Last Update

October 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Waterloo Rheumatology

Waterloo, Ontario, Canada, N2T 0C2